Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 43, 2019 - Issue 3
127
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with β-Thalassemia Major in Syria

ORCID Icon, , &
Pages 218-221 | Received 08 Apr 2019, Accepted 24 Jun 2019, Published online: 02 Aug 2019

References

  • Weatherall DJ. The thalassemias: disorders of globin synthesis. In: Kaushansky K, Lichman MA, Beutler E, et al., Editors. Williams Hematology, 8th ed. McGraw-Hill Professional (published online). 2010:675–707.
  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
  • Jarjour RA, Murad H, Moasses F, Al-Achkar W. Molecular update of β-thalassemia mutations in the Syrian population: identification of rare β-thalassemia mutations. Hemoglobin. 2014;38(4):272–276.
  • Al-Zir KN Prevention of hemoglobinopathies in Syria. Hemoglobin. 2009;33(Suppl 1):S25–S27.
  • Abdulzahra MS, Al-Hakeim HK, Ridha MM. Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients. Asian J Transfus Sci. 2011;5(2):127–131.
  • Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with β-thalassaemia major and intermedia. Endokrynol Polska. 2012;63(4):260–263.
  • Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol. 2011;4(3):353–366.
  • Waugh A, Grant A. The endocrine system. Ross and Wilson Anatomy and Physiology in Health and Illness, 10th ed. Edinburgh (UK): Elsevier. 2006:219–220.
  • Cappellini MD, Cohen A, Porter J, et al. Guidelines for the management of transfusion dependent thalassaemia (TDT), 3rd ed. Nicosia (Cyprus): Thalassaemia International Federation, 2014.
  • Soliman AT, Al Yafei, Al-Naimi L, et al. Longitudinal study on thyroid function in patients with thalassemia major: high incidence of central hypothyroidism by 18 years. Indian J of Endocrinol Metab. 2013;17(6):1090–1095.
  • Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB. Cross-talk between available guidelines for the management of patients with β-thalassemia major. Acta Haematol. 2013;130(2):64–73.
  • Pirinççioğlu AG, Deniz T, Gökalp D, et al. Assessment of thyroid function in children aged 1-13 years with β-thalassemia major. Iranian J Pediatr. 2011;21(1):77–82.
  • Malik SA, Syed S, Ahmed N. Frequency of hypothyroidism in patients of β-thalassaemia. J Pak Med Assoc. 2010;60(1):17–20.
  • Magro S, Puzzonia P, Consarino C, et al. Hypothyroidism in patients with thalassemia syndromes. Acta Haematol. 1990;84(2):72–76.
  • Chirico V, Laquanti A, Salpietro, V, et al. Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy. Eur J Endocrinol. 2013;169(6):785–793. [Erratum: Eur J Endocrinol. 2014;170(4):X3.]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.